About Nexelis
Nexelis is a company based in Laval (Canada) founded in 1989. Nexelis has completed 2 acquisitions, including AIT Bioscience and ImmunXperts. Nexelis offers products and services including Central Laboratories, Genomics, Discovery Sciences, and Labmatrix. Nexelis operates in a competitive market with competitors including BioAgilytix, Advion, Tentamus, Nordic Bioscience and Alderley Analytical, among others.
- Headquarter Laval, Canada
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
AIT Bioscience
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nexelis
Nexelis offers a comprehensive portfolio of products and services, including Central Laboratories, Genomics, Discovery Sciences, and Labmatrix.
Offers testing for clinical trials and drug development.
Supports precision medicine and clinical research applications.
Provides antibody discovery and immunogenicity testing.
Manages clinical trial samples and data securely.
Funding Insights of Nexelis
Investors in Nexelis
Nexelis has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ampersand Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
|
Locked | Locked | Locked |
Investor details for Nexelis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nexelis
Nexelis has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include AIT Bioscience and ImmunXperts.
Investment portfolio details for Nexelis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Human immune system-based bioassays are developed for drug applications.
|
Locked | Locked | 2014 | Locked | |
|
Bioanalytical CRO specializing in LC-MS/MS techniques and ligand binding assays
|
Locked | Locked | 2009 | Locked |
Complete acquisition details for Nexelis
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Nexelis
Detailed financials for Nexelis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nexelis Comparisons
Peer comparison for Nexelis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nexelis
Nexelis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioAgilytix, Advion, Tentamus, Nordic Bioscience and Alderley Analytical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Large-molecule bioanalysis is provided for biologics and biosimilars development.
|
|
| Locked | Locked | Locked |
Microfluidics and mass spectrometry products are provided for clinical research.
|
|
| Locked | Locked | Locked |
Analytical and quality assurance services are provided for diverse industries.
|
|
| Locked | Locked | Locked |
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
|
|
| Locked | Locked | Locked |
Bioanalytical assays for drug development are developed and validated.
|
|
| Locked | Locked | Locked |
Company offering a suite of scientific services for materials, engineering, agri, and life science industries
|
Detailed competitors of Nexelis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nexelis
Complete news archive for Nexelis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nexelis
Nexelis was founded in 1989 and raised its 1st funding round 29 years after it was founded.
Nexelis is headquartered in Laval, Canada. It is registered at Laval, Quebec, Canada.
Nexelis was established in 1989 and is based in Laval, Canada. Operations are centered on the life sciences sector, where assay development and bioanalytical services are delivered to support clinical and preclinical research. Testing solutions for drug development and validation are handled through specialized laboratories. The companys online presence is maintained at nexelis.com, facilitating global client access to these technical capabilities.
Nexelis's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.
Nexelis offers Central Laboratories, Genomics, Discovery Sciences, and Labmatrix.
Nexelis has made 2 acquisitions, including AIT Bioscience, and ImmunXperts.
Nexelis has 1 investor. Key investors include Ampersand Capital Partners.